Drug Profile
Research programme: PPAR pan agonists - Chipscreen Biosciences
Alternative Names: CS 204Latest Information Update: 06 Apr 2010
Price :
$50
*
At a glance
- Originator Chipscreen Biosciences
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Metabolic syndrome
Most Recent Events
- 06 Apr 2010 Discontinued for Metabolic syndrome in China (unspecified route)
- 15 Aug 2007 Early research in Metabolic syndrome in China (unspecified route)